Circulation et cohérence des notions

Value of the Information & Strength of the Argument

The talk provides valuable insights into the complex interplay of EU regulations in digital health. The speaker demonstrates a deep understanding of the regulatory landscape and effectively argues that while there are common approaches (risk-based, product-based), true interregulation is challenging due to differing risk assessments and authority competencies. The argumentation is coherent, though it is primarily an expert opinion without extensive empirical evidence. The speaker raises important questions about the feasibility of current regulatory frameworks, such as the capacity of the ANSM to evaluate AI risks in medical devices. The discussion of data governance and the European Health Data Space is particularly relevant, highlighting the tension between data protection and research needs. The talk is well-structured and logically progresses from general regulatory concepts to specific examples.

Scientific Rigor, Source Quality, Title Accuracy

The speaker references several key EU regulations and reports, including the AI Act, Medical Devices Regulation, and the OECD 2023 report on Privacy Enhancing Technologies. She also mentions the CNIL’s ‘GUS’ platform and the work of scholars like Bruno Latour and Jean-Marc Sauvé. However, specific citations are not provided in the transcript, and the talk is more of an expert commentary than a rigorous academic presentation. The title accurately reflects the content, focusing on the circulation and coherence of legal notions. The talk is part of a conference on ‘L’interrégulation des activités numériques’, which aligns with the topic. No comments were provided for analysis.

The title accurately reflects the content, which focuses on the circulation and coherence of legal notions across EU digital health regulations.

7/10

The speaker is a legal scholar (Maître de conférences en droit public) with expertise in digital health regulation. The presentation is well-structured, references specific EU regulations and institutional reports, and includes a nuanced discussion of regulatory challenges. However, it is an opinion/expert talk without formal citations or peer-reviewed sources, and some claims are not fully substantiated.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction: context of EU digital regulations and the topic of circulation and coherence of notions.
• 02:00Definition of regulation and interregulation, citing Bruno Latour and Jean-Marc Sauvé.
• 05:00Discussion of the EU's legal basis (Article 114 TFEU) for digital health regulations.
• 08:00Comparison of risk-based approaches in the AI Act and Medical Devices Regulation.
• 10:00Common elements: technical documentation, conformity assessment, CE marking, and multi-level governance.
• 12:00Concerns about the designation of authorities in France, particularly the ANSM's role in AI-integrated medical devices.
• 15:00Data governance: tension between protecting personal health data and enabling big data research.
• 18:00European Health Data Space and secondary use of health data.
• 20:00Role of regulatory authorities like CNIL and tools like Privacy Enhancing Technologies.
• 25:00Q&A: clarification of anonymization vs. pseudonymization.

• AI Act (Regulation (EU) 2024/1689) — Referenced as a key regulation in digital health, with risk-based approach.
• Medical Devices Regulation (Regulation (EU) 2017/745) — Referenced for its risk-based approach and governance structure.
• European Health Data Space Regulation (Regulation (EU) 2025/327) — Referenced for secondary use of health data.
• OECD Report on Privacy Enhancing Technologies (2023) — Referenced as a source for PETs.
• CNIL's GUS platform — Referenced as a tool for guiding actors in digital health.

• AI Act — Supports the speaker's description of the AI Act's risk-based approach.
• Medical Devices Regulation — Supports the comparison with the AI Act.